Fiduciary Group LLC cut its position in Clorox Co (NYSE:CLX) by 4.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,526 shares of the company’s stock after selling 495 shares during the period. Fiduciary Group LLC’s holdings in Clorox were worth $1,583,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new stake in shares of Clorox in the third quarter worth $130,000. Fort L.P. purchased a new position in Clorox during the second quarter valued at $129,000. IMS Capital Management purchased a new position in Clorox during the second quarter valued at $161,000. Successful Portfolios LLC purchased a new position in Clorox during the third quarter valued at $206,000. Finally, Lourd Capital LLC purchased a new position in Clorox during the third quarter valued at $214,000. 78.36% of the stock is owned by hedge funds and other institutional investors.
Several research firms recently weighed in on CLX. ValuEngine raised shares of Clorox from a “hold” rating to a “buy” rating in a research note on Saturday, September 22nd. Atlantic Securities began coverage on shares of Clorox in a research note on Thursday, September 20th. They set a “neutral” rating and a $151.00 target price for the company. Deutsche Bank cut shares of Clorox from a “hold” rating to a “sell” rating and set a $123.00 target price for the company. in a research note on Wednesday, October 10th. Argus raised shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 target price for the company in a research note on Tuesday, September 25th. Finally, Barclays set a $131.00 target price on shares of Clorox and gave the company a “hold” rating in a research note on Saturday, October 6th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $138.29.
CLX stock traded up $0.54 during trading on Thursday, hitting $149.97. 20,341 shares of the company’s stock traded hands, compared to its average volume of 1,197,594. Clorox Co has a 52 week low of $113.57 and a 52 week high of $153.38. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 3.15. The firm has a market capitalization of $19.21 billion, a P/E ratio of 23.92, a price-to-earnings-growth ratio of 3.11 and a beta of 0.36.
Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, August 2nd. The company reported $1.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.58 by $0.08. Clorox had a net margin of 13.44% and a return on equity of 103.18%. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.72 billion. During the same quarter last year, the business earned $1.53 earnings per share. Clorox’s quarterly revenue was up 2.7% compared to the same quarter last year. As a group, analysts anticipate that Clorox Co will post 6.41 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Shareholders of record on Wednesday, October 31st will be given a dividend of $0.96 per share. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 annualized dividend and a yield of 2.56%. Clorox’s dividend payout ratio (DPR) is currently 61.34%.
In other Clorox news, SVP Michael R. Costello sold 9,265 shares of the stock in a transaction on Monday, August 13th. The shares were sold at an average price of $140.02, for a total transaction of $1,297,285.30. Following the completion of the transaction, the senior vice president now owns 34,293 shares in the company, valued at $4,801,705.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Laura Stein sold 12,880 shares of the stock in a transaction on Friday, August 31st. The shares were sold at an average price of $144.10, for a total transaction of $1,856,008.00. Following the transaction, the executive vice president now owns 74,483 shares of the company’s stock, valued at approximately $10,733,000.30. The disclosure for this sale can be found here. Insiders have sold 29,268 shares of company stock valued at $4,196,686 in the last quarter. 1.00% of the stock is owned by company insiders.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Further Reading: Buyback For Investors Defined
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.